Interaction of nobiletin with methotrexate ameliorates 7-OH methotrexate-induced nephrotoxicity through endoplasmic reticulum stress-dependent PERK/CHOP signaling pathway. (March 2021)
- Record Type:
- Journal Article
- Title:
- Interaction of nobiletin with methotrexate ameliorates 7-OH methotrexate-induced nephrotoxicity through endoplasmic reticulum stress-dependent PERK/CHOP signaling pathway. (March 2021)
- Main Title:
- Interaction of nobiletin with methotrexate ameliorates 7-OH methotrexate-induced nephrotoxicity through endoplasmic reticulum stress-dependent PERK/CHOP signaling pathway
- Authors:
- Song, Yurong
Liu, Linlin
Liu, Bin
Liu, Rui
Chen, Youwen
Li, Chenxi
Liu, Guangzhi
Song, Zhiqian
Lu, Cheng
Lu, Aiping
Liu, Yuanyan - Abstract:
- Graphical abstract: Highlights: The 7−OH MTX was the main culprit for MTX nephrotoxicity. PERK/CHOP mediated ER stress was screened as key pathway by RNA-seq analysis. Nobiletin could ameliorate the nephrotoxicity of 7−OH MTX through PERK/CHOP pathway. Nobiletin could maintain Ca 2+ homeostasis and reduce the production of ROS. Abstract: Drug-induced nephrotoxicity is a frequent adverse event that contributes to acute kidney injury with tubular and/or glomerular lesions. Methotrexate (MTX) is a folate analog used against a myriad of malignancies and autoimmune diseases. Unfortunately, ambiguous renal toxicology limits its safe clinical usage. Based on our previous studies, 7−OH MTX as an overlooked oxidative metabolite of MTX was proposed to be the main culprit responsible for nephrotoxicity, while nobiletin, a naturally occurring polymethoxylated flavonoid screened from our prepared total phenolic extracts of Citrus aurantium L. (TPE-CA), was employed as a therapeutic agent for drug-drug interactions. According to the present study, nobiletin can ameliorate the renal accumulation of 7−OH MTX through the interaction with aldehyde oxidase. RNA-seq analysis revealed that 7−OH MTX was mainly related to protein processing in endoplasmic reticulum (ER) stress, with the PERK/CHOP pathway selected as the most significant for metabolic nephrotoxicity. Meanwhile, the cross-linked proteins and conducted signals were investigated by western blotting and further verified by GSKGraphical abstract: Highlights: The 7−OH MTX was the main culprit for MTX nephrotoxicity. PERK/CHOP mediated ER stress was screened as key pathway by RNA-seq analysis. Nobiletin could ameliorate the nephrotoxicity of 7−OH MTX through PERK/CHOP pathway. Nobiletin could maintain Ca 2+ homeostasis and reduce the production of ROS. Abstract: Drug-induced nephrotoxicity is a frequent adverse event that contributes to acute kidney injury with tubular and/or glomerular lesions. Methotrexate (MTX) is a folate analog used against a myriad of malignancies and autoimmune diseases. Unfortunately, ambiguous renal toxicology limits its safe clinical usage. Based on our previous studies, 7−OH MTX as an overlooked oxidative metabolite of MTX was proposed to be the main culprit responsible for nephrotoxicity, while nobiletin, a naturally occurring polymethoxylated flavonoid screened from our prepared total phenolic extracts of Citrus aurantium L. (TPE-CA), was employed as a therapeutic agent for drug-drug interactions. According to the present study, nobiletin can ameliorate the renal accumulation of 7−OH MTX through the interaction with aldehyde oxidase. RNA-seq analysis revealed that 7−OH MTX was mainly related to protein processing in endoplasmic reticulum (ER) stress, with the PERK/CHOP pathway selected as the most significant for metabolic nephrotoxicity. Meanwhile, the cross-linked proteins and conducted signals were investigated by western blotting and further verified by GSK inhibition analyses. These results indicated that nobiletin protected renal function from MTX-induced nephrotoxicity by modulating metabolism and ameliorated the metabolic toxicity of 7−OH MTX on ER stress-induced PERK/CHOP conduction by maintaining Ca 2+ homeostasis and reducing the production of reactive oxygen species. … (more)
- Is Part Of:
- Pharmacological research. Volume 165(2021)
- Journal:
- Pharmacological research
- Issue:
- Volume 165(2021)
- Issue Display:
- Volume 165, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 165
- Issue:
- 2021
- Issue Sort Value:
- 2021-0165-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-03
- Subjects:
- Methotrexate (PubChem CID: 126941) -- Nobiletin (PubChem CID: 72344) -- 7−OH Methotrexate (PubChem CID: 5484402)
7−OH MTX -- Acute kidney injury -- Endoplasmic reticulum stress -- Nobiletin -- PERK/CHOP signaling pathway
Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.phrs.2020.105371 ↗
- Languages:
- English
- ISSNs:
- 1043-6618
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16183.xml